相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risk Factors for Invasive Candida Infection in Critically Ill Patients A Systematic Review and Meta-analysis
Daniel O. Thomas-Ruddel et al.
CHEST (2022)
Candida colonization as a predictor of invasive candidiasis in non-neutropenic ICU patients with sepsis: A systematic review and meta-analysis
Hameid Alenazy et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Performance of Repeated Measures of (1-3)-β-D-Glucan, Mannan Antigen, and Antimannan Antibodies for the Diagnosis of Invasive Candidiasis in ICU Patients: A Preplanned Ancillary Analysis of the EMPIRICUS Randomized Clinical Trial
Claire Dupuis et al.
OPEN FORUM INFECTIOUS DISEASES (2021)
(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial
Gennaro De Pascale et al.
CRITICAL CARE (2020)
Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis
P. Koehler et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project
Matteo Bassetti et al.
CRITICAL CARE (2019)
Management of invasive candidiasis and candidaemia in critically ill adults: expert opinion of the European Society of Anaesthesia Intensive Care Scientific Subcommittee
R-A. O'Leary et al.
JOURNAL OF HOSPITAL INFECTION (2018)
False positive serum levels of (1-3)-beta-D-Glucan after infusion of intravenous immunoglobulins and time to normalisation
M. Egger et al.
JOURNAL OF INFECTION (2018)
(1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culturebased diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): study protocol for a randomized controlled trial
Frank Bloos et al.
TRIALS (2018)
Serum 1,3-Beta-D-Glucan Values During and After Laparoscopic and Open Intestinal Surgery
Alexander Szyszkowitz et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
Biomarker-based strategy for early discontinuation of empirical antifungal treatment in critically ill patients: a randomized controlled trial
Anahita Rouze et al.
INTENSIVE CARE MEDICINE (2017)
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2016)
1,3-β-d-Glucan contamination of common antimicrobials
B. Liss et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
1,3-ss-D-glucan concentrations in blood products predict false positive post-transfusion results
B. Liss et al.
MYCOSES (2016)
Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure The EMPIRICUS Randomized Clinical Trial
Jean-Francois Timsit et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Mervyn Singer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study
Brunella Posteraro et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock A Randomized Clinical Trial
Frank Bloos et al.
JAMA INTERNAL MEDICINE (2016)
Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions
Cristobal Leon et al.
CRITICAL CARE (2016)
β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis
Estrella Martin-Mazuelos et al.
INTENSIVE CARE MEDICINE (2015)
Interference of confounding factors on the use of (1,3)-beta-D-glucan in the diagnosis of invasive candidiasis in the intensive care unit
G. Lo Cascio et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2015)
Invasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006–2008)
L. Klingspor et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
MSG-01: A Randomized, Double-Blind, Placebo-Controlled Trial of Caspofungin Prophylaxis Followed by Preemptive Therapy for Invasive Candidiasis in High-Risk Adults in the Critical Care Setting
Luis Ostrosky-Zeichner et al.
CLINICAL INFECTIOUS DISEASES (2014)
β-Glucan Antigenemia Anticipates Diagnosis of Blood Culture-Negative Intraabdominal Candidiasis
Frederic Tissot et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Limitation of (1→3)-β-D-glucan monitoring in major elective surgery involving cardiopulmonary bypass
Gordon P. Otto et al.
CRITICAL CARE (2013)
Septic Shock Attributed to Candida Infection: Importance of Empiric Therapy and Source Control
Marin Kollef et al.
CLINICAL INFECTIOUS DISEASES (2012)
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
O. A. Cornely et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Effect of Empirical Treatment With Moxifloxacin and Meropenem vs Meropenem on Sepsis-Related Organ Dysfunction in Patients With Severe Sepsis A Randomized Trial
Frank M. Brunkhorst et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Prospective Survey of (1 -> 3)-beta-D-Glucan and Its Relationship to Invasive Candidiasis in the Surgical Intensive Care Unit Setting
John F. Mohr et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Usefulness of the Candida score for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: A prospective multicenter study
Cristobal Leon et al.
CRITICAL CARE MEDICINE (2009)
Empirical fluconazole versus placebo for intensive care unit patients - A randomized trial
Mindy G. Schuster et al.
ANNALS OF INTERNAL MEDICINE (2008)
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Ben De Pauw et al.
CLINICAL INFECTIOUS DISEASES (2008)
Intensive insulin therapy and pentastarch resuscitation in severe sepsis
Frank M. Brunkhorst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Early presumptive therapy with fluconazole for occult Candida infection after gastrointestinal surgery
YS Shan et al.
WORLD JOURNAL OF SURGERY (2006)
Multicenter clinical evaluation of the (1→3) β-D-glucan assay as an aid to diagnosis of fungal infections in humans
L Ostrosky-Zeichner et al.
CLINICAL INFECTIOUS DISEASES (2005)
Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients
R Piarroux et al.
CRITICAL CARE MEDICINE (2004)
Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS Prospective Multicenter Study
HM Blumberg et al.
CLINICAL INFECTIOUS DISEASES (2001)
分享论文
